NEW YORK (GenomeWeb) – Horizon Discovery reported on Tuesday that its preliminary 2017 revenues rose 52 percent year over year, thanks largely to a 101 percent increase in product revenues.

For the 12 months ended Dec. 31, the gene editing firm said revenues rose to £36.5 million ($49.2 million) from £24.1 million in 2016. Organic revenues excluding the acquisition of Dharmacon increased 14 percent to £27.5 million.

Product revenues rose to £22.8 million while services revenues increased 7 percent to £13.7 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.